Most side effects are mild-to-moderate and improve over time
As insufficient supply problems persist, the European Medicines Agency considers this a major public health concern. It has advised medical professionals to only prescribe these medicines for their licensed uses and that it is necessary to strictly adhere to national clinical practice guidelines
The criteria for both Mounjaro and Wegovy are: BMI of 30 or above, or BMI of 27 or above with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea) If your BMI is below 27, you wont currently be eligible for GLP-1 medication for weight management through the NHS or private prescribers in the UK 7,8
When issues do arise, its absolutely crucial to take action with a remediation project designed to identify and remedy the root causes of the problems at hand
The answer is that cagrilintide is the harder peptide of the two to make
This explains why the Kind Patches ingredient list does not include actual GLP-1